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D 3 Outcome Assessment Methodology in Critical Limb Ischemia
Critical limb ischemia represents a chronic reduction in distal blood flow to the extent that via-
bility of the limb is threatened. Manifestations of this degree of hypoperfusion include rest pain,
nonhealing wounds and ulcers, or ischemic gangrene. Such a profound reduction in peripheral
blood flow is associated with severe, diffuse atherosclerosis and increased likelihood of death.
Despite aggressive correction of distal ischemia, these patients have a limited life expectancy,
with less than 60% surviving more than 3 years after treatment1,2,3 (see A 2.7, Fate of Patients
With CLI, p 523).
The therapeutic goals for the treatment of critical limb ischemia must reflect the clinical status of
the patient. An ideal treatment would improve both the functional status of the leg and the life
expectancyand functional status of the patient. Unfortunately, such interventions have not yet
been developed. Treatments must be directed both at the systemic process, through control of
risk factors, and at improvement in distal perfusion. The extent to which distal perfusion must be
improved depends on the general health and functional status of the patient and the likelihood
of successful improvement in these states. The overall outcomes assessment of procedures direct-
ed toward treatment of CLI must account for the fragile status of this patient population.
Recommendation 80: Parameters for reporting success of treatment for critical limb
ischemia
Success of treatment for critical limb ischemia should take into account an improve-
ment in the following:
Objective outcome: Complete healing of skin lesions. Standardized reporting criteria
should include technical success, hemodynamic testing, procedural morbidity, limb
function, and amputation and mortality rates.
Symptomatic outcome: Relief of pain
• General quality of life: As assessed by a generic health status instrument
• Post-revascularization: Proof of patency of the revascularized segment as defmed in
A 3.2.9, Recommendation 5
D 3.1.1 Clinical Measures
Technical success
Technical success identifies the achievement ofthe intended technical objective(s) of the com-
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plete procedure. Although treatment of critical limb ischemia may require more than one treat-
ment modality, for example, thrombolytic therapy and bypass grafting, technical success should
be reported as successful achievement of the desired result after all necessary therapeutic proce-
dures have been performed (see Recommendation 51, p S147). Technical success does not
require the restoration of palpable pedal pulses in all cases. Many procedures, such as profun-
daplasty, may provide increased distal perfusion through collateral beds. Conversely, the techni-
cal inability to carry out the intended therapeutic plan should be reported as a technical failure.
For example, the inability to successfully lyse clot or construct a distal bypass to a diminutive
distal vessel constitutes a technical failure.
(Repeatedfrom p 8147)
Recommendation 51: Assessment of technical success of multiple interventions
When treatment involves multiple modalities, such as thrombolytic therapy and open
surgery, "technical success" should be reported as overall technical success during the
same hospitalization period rather than the success of each component of therapy,
although the success of each component of therapy also should be reported.
Improvement in ankle:brachial index
Successful revascularization should lead to an increase in ankle-brachial index (see A 3.2.4,
Objective Outcome Measures, p 538). In the setting of heavily calcified distal vessels, it is
appropriate to use toe pressures or evaluation of pulse volume recordings or the pole tests to
determine hemodynamic success.
Arterial/graftpatency
Appropriate follow-up studies to confirm patency of the treated artery or bypass graft are
reviewed in Patency (A 3.2.9, P S42) and Surveillance After Revascularization, D 4.14, P S253).
Primary patency implies uninterrupted patency after performance of the procedure(s). Assisted
primary patency refers to those patent arteries or grafts that have required additional interven-
tion but have not thrombosed. Secondary patency identifies those arteries or grafts that have
failed but were reopened by an additional intervention.
Limb salvage
Limb salvage after treatment for chronic critical limb ischemia (CLI) is defined as preservation
of a functional foot. Because patients with advanced CLI may present with ischemic gangrene of
the toes, forefoot, or heel, removal of this necrotic tissue is an essential part of any therapeutic
regimen. Loss of the toes, forefoot, and midfoot do not significantlyalter the work of arnbula-
tion and therefore may assist in the achievement of a functional limb. Amputation above the
level of the proximal forefoot constitutes failure of limb salvage, whether or not revasculariza-
tion has been accomplished.
Recommendation 81: Reporting limb salvage after treatment of critical limb ischemia
For reporting purposes, successful limb salvage after treatment of critical limb ischemia
is defined as the preservation of a functional limb, including at least part of the foot,
without requirement for a prosthesis.
Healing of wounds
Complete healing refers to a continuous viable, epithelial covering over all previously open
wounds. Long incisions are often required for surgical intervention. Complete healing of
wounds in patients undergoing treatment of eLI must include the index lesions present at the
time therapy is initiated as well as all surgical incisions required for patient treatment.
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Short-term morbidity
Short-term morbidity of the treatment of patients with CLI must include complications associ-
ated with major diagnostic procedures and with therapeutic interventions. Minor complications
that do not necessitate additional diagnostic tests, prolong hospitalization or recuperation, or
require treatment need not be considered in the assessment of patient morbidity.
Procedural mortality
Procedural mortality is defined as death within 30 days of the intervention or within the same
hospitalization as the intervention, if this is longer than 30 days. Traditionally, the standard has
been to report as procedural mortality only those patients who die within 30 days of therapy.
Patients with CLI, however, often have severe comorbid conditions that may be worsened by
the procedure. These in-hospital events, such as myocardial infarction, respiratory failure, sepsis,
and stroke, may be rapidly detected and treatment undertaken that prevents immediate death,
but ultimately death ensues weeks or months later. Such patients should be reported in the
assessment of procedural mortality.
Symptomatic improvement
As described in A 3.2.5, Symptomatic Outcome Measures, (p S38 ), symptomatic improvement
can be determined using one of the accepted classification scales, such as the Fontaine or
Rutherford scale. Symptomatic improvement requires a movement upward of at least one cate -
gory without preexisting tissue loss or two categories if pretreatment tissue loss is present.
Impr01Jement in quality of life
Currently, there are no quality-of-life instruments that have been standardized in a large popula-
tion of patients requiring treatment for CLI (see also Critical Issue 2, p S39). The most com-
monly used generic instrument, the SF-36 questionnaire, has been used by some investigators in
the evaluation of small groups of patients to determine whether its scale appropriately reflects
the benefits of successful treatment. Functional status should be followed-up for at least 6
months postprocedure. Schneider and associates- used the SF-20, similar to the SF-36, a deriva-
tive of the Medical Outcomes Study, to evaluate 60 patients with CLI. This group noted that
those with CLI had significant decreases in functional health and well-being despite successful
revascularization.
Duggan and colleagucss used the SF-36 questionnaire for the evaluation of 21 patients requiring
treatment for CLI. Interestingly, they noted no significant difference in physical functioning
between those patients with patent and those with failed bypasses. Additionally, the SF-36 did not
indicate that patients with functioning bypasses had better emotional and general well-being scores.
Chetter and associates? also employed the SF-36 to evaluate 235 patie.nts, 78 of whom had CLI.
They noted that the quality-of-life scores obtaine.d through me SF-36 deteriorated as distal perfu-
sion worsened. Thus, although there has been no broad standardization of the SF-36 in. patients
with CLI, it represents the most obvious option at the present (see Recommendation 3, p 841) .
Improvement in functional status
Improvement in functional status is often difficult to define in patients with CLI because of the
presence of numerous and often severe cornorbid conditions. Simple assessment of walking dis-
tance, though useful in some patients, does not apply to many, For example, those patients who
have had a previous major amputation of the contralateral extremity may have an improved abil-
ity to pivot and transfer from bed to wheelchair after successful revascularization of the con-
tralateral leg . This improvement would not be detected by any current measures of functional
status. Therefore, specific instruments capable of detecting improvement in functional status in
this diverse patient population must be developed.
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